Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Graft Lymphocyte Content Does Not Influence Outcomes after Peripheral Blood Haploidentical Transplants Using Post Transplant Cyclophosphamide (PTCy)

Steven H Borson, MD, Michael Slade, BA, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Mark A. Schroeder, MD, Rizwan Romee, MD, Cory Jensen, BS

Blood (2016) 128 (22): 5883.

https://doi.org/10.1182/blood.V128.22.5883.5883

Published: 2016

Journal Articles

Reduced Intensity Hematopoietic Cell Transplantation in Active Disease AML Is Associated with Leukemia Free Survival and Relapse Comparable to Myeloablative Conditioning

Se young Han, MD, Rizwan Romee, MD, Michael Slade, BA, Pavan Kumar Bhamidipati, MBBS, MD, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Ravi Vij, Yu Tao, PhD

Blood (2016) 128 (22): 3477.

https://doi.org/10.1182/blood.V128.22.3477.3477

Published: 2016

Journal Articles

Risk Factors for the Development of and Outcomes of Patients Who Develop Severe Cytokine Release Syndrome after Peripheral Blood Haploidentical Donor Transplant

Ramzi Abboud, MD, Michael Slade, BA, Wenners Ballard, III, MD, Jesse Keller, MD, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Camille N. Abboud, MD, Todd A Fehniger, MD PhD, Kathryn Trinkaus, Rizwan Romee, MD

Blood (2016) 128 (22): 3419.

https://doi.org/10.1182/blood.V128.22.3419.3419

Published: 2016

Journal Articles

Haploidentical Transplant with Peripheral Blood Hematopoietic Cell Grafts in Older Adults with AML or MDS

Michael Slade, BA, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Ravi Vij, Geoffrey L. Uy, MD, Mark A. Schroeder, MD, Rizwan Romee, MD

Blood (2016) 128 (22): 4658.

https://doi.org/10.1182/blood.V128.22.4658.4658

Published: 2016

Journal Articles

The Use of CD34 + -Selected Stem Cell Boosts Following HLA-Haploidentical Hematopoietic Cell Transplantation

Michael Slade, BA, Scott R Goldsmith, MD, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Ravi Vij, Todd A Fehniger, MD PhD, Mark A. Schroeder, MD, Rizwan Romee, MD

Blood (2016) 128 (22): 4697.

https://doi.org/10.1182/blood.V128.22.4697.4697

Published: 2016

Journal Articles

Absolute Lymphocyte Count Recovery Predicts Post Transplant Outcomes in Peripheral Blood Haploidentical Transplantation

Jason Thomas Romancik, MD, Michael Slade, BA, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Kathryn Trinkaus, PhD, Rizwan Romee, MD

Blood (2016) 128 (22): 4698.

https://doi.org/10.1182/blood.V128.22.4698.4698

Published: 2016

Journal Articles

ABO Mismatch Status Does Not Influence the Clinical Outcomes in Haploidentical Hematopoeitic Cell Transplantation

Bita Fakhri, MD MPH, Michael Slade, BA, Cory Jensen, BS, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Rizwan Romee, MD

Blood (2016) 128 (22): 4699.

https://doi.org/10.1182/blood.V128.22.4699.4699

Published: 2016

Journal Articles

Post-Transplant Outcomes in AML Patients ≥ 60 Years of Age Beyond CR1

Dhruv Bansal, MD, Pavan Kumar Bhamidipati, MBBS, MD, Natasha Catherine Edwin, MD, Michael Slade, BA, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Ravi Vij, MD, Mark A. Schroeder, MD, Geoffrey L. Uy, MD, Jingxia Liu, Rizwan Romee, MD

Blood (2016) 128 (22): 4696.

https://doi.org/10.1182/blood.V128.22.4696.4696

Published: 2016

Journal Articles

Haploidentical Hematopoietic Cell Transplantation Using G-CSF Mobilized T-Cell Replete Grafts for for Acute Leukemia and MDS

Eric Huselton, MD, Rizwan Romee, MD, Michael Slade, BA, Cory Jenson

Blood (2016) 128 (22): 2278.

https://doi.org/10.1182/blood.V128.22.2278.2278

Published: 2016

Journal Articles

The Association of International Staging System (ISS) Stage with Disease and Symptom Burden in Patients with Newly Diagnosed Multiple Myeloma

Mark A Fiala, BS, CCRP, Michael Slade, BA, Jesse Keller, MD, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Tanya M Wildes, MD MSCI, Ravi Vij, MD MBA

Blood (2015) 126 (23): 2115.

https://doi.org/10.1182/blood.V126.23.2115.2115

Published: 2015

Journal Articles

Presenting Characteristics and Symptom Burden of Newly Diagnosed Older Multiple Myeloma Patients in the Commpass Study

Jesse Keller, MD, Mark A Fiala, BS, CCRP, Michael Slade, BA, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Tanya M Wildes, MD MSCI, Ravi Vij, MD MBA

Blood (2015) 126 (23): 3307.

https://doi.org/10.1182/blood.V126.23.3307.3307

Published: 2015

Journal Articles

The Association Between Performance Status and Health-Related Quality of Life

Mark A Fiala, BS, CCRP, Jesse Keller, MD, Michael Slade, BA, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Ravi Vij, MD MBA, Tanya M Wildes, MD MSCI

Blood (2015) 126 (23): 3312.

https://doi.org/10.1182/blood.V126.23.3312.3312

Published: 2015

Journal Articles

T-Cell Replete Peripheral Blood Haploidentical Donor Transplant Is Frequently Associated with Cytokine Release Syndrome Which Responds to Anti-IL-6 Therapy

Ramzi Abboud, MD, Jesse Keller, MD, Michael Slade, BA, Michael P. Rettig, PhD, Stephanie Meier, John F. DiPersio, MD PhD, Todd A Fehniger, MD PhD, Kathryn Trinkaus, Geoffrey L. Uy, MD, Peter Westervelt, MD PhD, Ravi Vij, MD, Camille N. Abboud, MD FACP, Khoan Vu, MD, Pavan Kumar Bhamidipati, MBBS,MD, Rizwan Romee, MD

Blood (2015) 126 (23): 3106.

https://doi.org/10.1182/blood.V126.23.3106.3106

Published: 2015

Journal Articles

Variations in Multiple Myeloma Disease Presentation By Race

Mark A Fiala, BS, CCRP, Tanya M Wildes, MD MSCI, Michael Slade, BA, Jesse Keller, MD, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Ravi Vij, MD MBA

Blood (2015) 126 (23): 5618.

https://doi.org/10.1182/blood.V126.23.5618.5618

Published: 2015

NARROW

Graft Lymphocyte Content Does Not Influence Outcomes after Peripheral Blood Haploidentical Transplants Using Post Transplant Cyclophosphamide (PTCy)

Reduced Intensity Hematopoietic Cell Transplantation in Active Disease AML Is Associated with Leukemia Free Survival and Relapse Comparable to Myeloablative Conditioning

Risk Factors for the Development of and Outcomes of Patients Who Develop Severe Cytokine Release Syndrome after Peripheral Blood Haploidentical Donor Transplant

Haploidentical Transplant with Peripheral Blood Hematopoietic Cell Grafts in Older Adults with AML or MDS

The Use of CD34 + -Selected Stem Cell Boosts Following HLA-Haploidentical Hematopoietic Cell Transplantation

Absolute Lymphocyte Count Recovery Predicts Post Transplant Outcomes in Peripheral Blood Haploidentical Transplantation

ABO Mismatch Status Does Not Influence the Clinical Outcomes in Haploidentical Hematopoeitic Cell Transplantation

Post-Transplant Outcomes in AML Patients ≥ 60 Years of Age Beyond CR1

Haploidentical Hematopoietic Cell Transplantation Using G-CSF Mobilized T-Cell Replete Grafts for for Acute Leukemia and MDS

The Association of International Staging System (ISS) Stage with Disease and Symptom Burden in Patients with Newly Diagnosed Multiple Myeloma

Presenting Characteristics and Symptom Burden of Newly Diagnosed Older Multiple Myeloma Patients in the Commpass Study

The Association Between Performance Status and Health-Related Quality of Life

T-Cell Replete Peripheral Blood Haploidentical Donor Transplant Is Frequently Associated with Cytokine Release Syndrome Which Responds to Anti-IL-6 Therapy

Variations in Multiple Myeloma Disease Presentation By Race

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only